Mérida-De la Torre FJ - Search Results

1

Identifying risk in the use of tumor markers to improve patient safety.

Moreno-Campoy EE, Mérida-De la Torre FJ, Martos-Crespo F, Plebani M. Moreno-Campoy EE, et al. Among authors: merida de la torre fj. Clin Chem Lab Med. 2016 Dec 1;54(12):1947-1953. doi: 10.1515/cclm-2015-0760. Clin Chem Lab Med. 2016. PMID: 26953709

2

Letter to the Editor in reply to Dayyani and Morgenstern's comment on the article "Identifying risk in the use of tumor markers to improve patient safety".

Moreno-Campoy EE, Mérida-De la Torre FJ, Martos-Crespo F, Plebani M. Moreno-Campoy EE, et al. Among authors: merida de la torre fj. Clin Chem Lab Med. 2016 Dec 1;54(12):e385-e386. doi: 10.1515/cclm-2016-0546. Clin Chem Lab Med. 2016. PMID: 27533121 No abstract available.

3

[Gender differences in the use of tumour markers].

Moreno-Campoy EE, Mérida-De la Torre FJ, Martos-Crespo F, Plebani M. Moreno-Campoy EE, et al. Among authors: merida de la torre fj. Rev Calid Asist. 2015 Nov-Dec;30(6):327-34. doi: 10.1016/j.cali.2015.06.008. Epub 2015 Sep 26. Rev Calid Asist. 2015. PMID: 26410238 Spanish.

4

[Impact of the implementation of a protocol for the adequate and safe use of tumor markers].

Mérida de la Torre FJ, Moreno Campoy EE, Martos Crespo F. Mérida de la Torre FJ, et al. Med Clin (Barc). 2015 Dec 21;145(12):526-8. doi: 10.1016/j.medcli.2015.04.031. Epub 2015 Jul 10. Med Clin (Barc). 2015. PMID: 26169333 Clinical Trial. Spanish.

5

Diagnostic role of tumor markers.

Mérida de la Torre FJ, Moreno Campoy EE. Mérida de la Torre FJ, et al. Med Clin (Barc). 2019 Mar 1;152(5):185-187. doi: 10.1016/j.medcli.2018.10.011. Epub 2018 Nov 27. Med Clin (Barc). 2019. PMID: 30502299 English, Spanish. No abstract available.

6

[Influence of an observer in the haemolysis produced during the extraction of blood samples in primary care].

Bel-Peña N, Mérida-de la Torre FJ. Bel-Peña N, et al. Among authors: merida de la torre fj. Rev Calid Asist. 2015 Nov-Dec;30(6):297-301. doi: 10.1016/j.cali.2015.07.008. Epub 2015 Nov 3. Rev Calid Asist. 2015. PMID: 26546170 Spanish.

7

[Expanding the portfolio of laboratory services in primary care does not increase the cost].

Mérida de la Torre FJ, Bel Peña N. Mérida de la Torre FJ, et al. Semergen. 2020 Jan-Feb;46(1):41-45. doi: 10.1016/j.semerg.2019.09.003. Epub 2019 Nov 19. Semergen. 2020. PMID: 31757718 Spanish.

8

[Pre and post-operative autotransfusion. A comparative study of hematology, biochemistry and red cell metabolism in pre-donated blood and blood from post-operative surgical drainage].

Muñoz Gómez M, Sánchez Arrieta Y, García Vallejo JJ, Mérida de la Torre FJ, Ruíz Romero de la Cruz MD, Eloy-García JM. Muñoz Gómez M, et al. Among authors: merida de la torre fj. Sangre (Barc). 1999 Dec;44(6):443-50. Sangre (Barc). 1999. PMID: 10822758 Spanish.

9

[Chronic metabolic syndrome: a predictive model of risk of macrovascular events?].

Sánchez Luque JJ, Ortiz García C, Rojano Martín JC, Mérida de la Torre FJ, Luque Martín JS, Morell Ocaña M. Sánchez Luque JJ, et al. Aten Primaria. 1997 Sep 15;20(4):168-72. Aten Primaria. 1997. PMID: 9410138 Spanish.

10

[Transverse myelitis caused by Brucella].

Sánchez Chaparro MA, Mérida de la Torre FJ, González Alegre P, González Santos P. Sánchez Chaparro MA, et al. Among authors: merida de la torre fj. Rev Clin Esp. 1999 Nov;199(11):778. Rev Clin Esp. 1999. PMID: 10638250 Spanish. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters